Thermic Sciences International (ENDO) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerThermic Sciences International (ENDO) trades at $0.0001. Thermic Sciences International, formerly OmniCanna Health Solutions, Inc., specializes in hemp-based health, wellness, cosmeceutical, nutraceutical, and food products. Sector: Technology.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for ENDO: ENDO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Thermic Sciences International (ENDO) Technology Profile & Competitive Position
Thermic Sciences International (ENDO) is a Colorado-based company established in 1969, specializing in the development and international distribution of hemp-based health, wellness, cosmeceutical, nutraceutical, and food products. The company's diverse portfolio includes personal care items and formulations targeting various health conditions, reaching markets across North America, Europe, and Asia.
What Is the Investment Thesis for ENDO?
Thermic Sciences International operates within the Basic Materials sector, specifically the Chemicals - Specialty industry, focusing on the development and international distribution of hemp-based products. The company's business model is centered on leveraging a diverse product portfolio, ranging from general health and wellness to targeted therapeutic solutions for conditions such as HIV/AIDS and cancer, distributed across multiple continents. A potential strength lies in the company's ability to innovate within its chosen market niche, offering a wide array of cosmeceuticals, nutraceuticals, and food items. However, the company faces significant financial distress, evidenced by an extremely low market capitalization of $0.00B (specifically $6,789) and a stock price of $0.00. Its listing on the OTC Other tier further signals limited public disclosure and heightened investment risk. Investors should prioritize closely monitoring the company's financial filings, news releases, and any potential restructuring plans to assess its operational viability and strategic direction given its current financial position.
Based on FMP financials and quantitative analysis
ENDO Key Highlights
Market Capitalization of $0.00B ($6,789) indicates an extremely low valuation and significant financial distress.
- Current stock price of $0.00 reflects the company's distressed financial state and speculative nature.
- Beta of -8.33 suggests an inverse relationship with broader market movements, though this extreme value may point to low liquidity or specific trading dynamics rather than typical market correlation.
- Dividend Yield is None, as the company does not currently distribute dividends to shareholders.
- Trades on the OTC Other tier, signifying limited public disclosure requirements and higher inherent investment risk compared to major exchanges.
Who Are ENDO's Competitors?
ENDO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MITQ Moving iMage Technologies, Inc. | $0.58 | +5.11% | $5.75M | 37 5-pillar |
| SONM Sonim Technologies, Inc. | $4.08 | -1.57% | $6.07M | — |
| SYNX Silynxcom Ltd. | $1.01 | +3.06% | $6.70M | — |
| CLRO ClearOne, Inc. | $4.08 | -18.40% | $10.9M | — |
| BOSC B.O.S. Better Online Solutions Ltd. | $4.63 | 0.00% | $32.6M | 79 5-pillar |
| CMTL Comtech Telecommunications Corp. | $1.32 | -0.75% | $39.6M | 35 5-pillar |
| MOB Mobilicom Ltd. | $4.21 | -2.55% | $50.4M | — |
| AIRG Airgain, Inc. | $4.61 | +8.47% | $58.4M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ENDO's Key Strengths?
Diverse product portfolio encompassing health, wellness, personal care, nutraceuticals, and targeted therapeutic hemp-based solutions.
- Extensive international distribution network reaching multiple countries across North America, Europe, and Asia.
- Long operational history, established in 1969, suggesting experience in the market.
- Potential for innovation in developing specialized hemp-based products for specific health conditions.
What Are ENDO's Weaknesses?
Extremely low market capitalization of $6,789 and a stock price of $0.00, indicating significant financial distress.
- Trading on the OTC Other tier, which implies limited public disclosure and higher investment risk.
- Unknown disclosure status, making it difficult for investors to access comprehensive financial information.
- Negative Beta of -8.33, which may indicate highly unusual trading patterns or extremely low liquidity.
What Are the Key Risks for ENDO?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant financial distress, characterized by an extremely low market capitalization of $6,789 and a stock price of $0.00.
- High operational and investment risk associated with trading on the OTC Other tier, including limited public disclosure and extremely low liquidity.
- Inability to secure necessary funding or capital for continued operations, research and development, or growth initiatives.
- Intense competition within the global hemp-based products market, potentially impacting market share and profitability.
- Adverse regulatory changes or increased scrutiny in the various international markets where the company distributes its hemp products.
What Threats Does ENDO Face?
- Intense competition from established players and new entrants in the rapidly expanding hemp products market.
- Significant financial distress and extremely low market capitalization pose a risk to ongoing operations and sustainability.
- Regulatory changes or restrictions on hemp cultivation, processing, and sales in international markets.
- Challenges in securing adequate capital and funding for operations, R&D, and expansion given its current financial state.
- Reputational risks associated with trading on the OTC Other tier, potentially deterring institutional investors.
What Are ENDO's Competitive Advantages?
- Diverse product portfolio spanning health, wellness, cosmeceuticals, nutraceuticals, and targeted therapeutic applications, all utilizing hemp.
- Established international distribution network reaching multiple continents, facilitating broad market access.
- Long operating history since 1969, providing a foundation of experience in product development and market presence.
- Focus on developing products for specific health conditions, potentially creating niche market advantages.
- Potential for innovation within the hemp-based product market, allowing for unique product offerings.
What Does ENDO Do?
Thermic Sciences International, established in 1969 and headquartered in Colorado Springs, Colorado, has evolved from its origins as OmniCanna Health Solutions, Inc. The company's core business revolves around the creation and market introduction of an extensive array of hemp-based products. This diverse portfolio spans multiple consumer categories, including health and wellness solutions, cosmeceuticals, nutraceuticals, and food items, all formulated with hemp. Within its product line, Thermic Sciences International offers a selection of over-the-counter personal care goods designed for hair and skin. These include specific offerings such as Hempery miracle oil, a specialized skincare treatment; Hemp milk body wash, characterized as a rich, creamy soap; Hemp lotion bars, formulated for comprehensive moisturizing; Hemp rose soap; and Hemtastique lip and body balms. Beyond general wellness and personal care, the company demonstrates a strategic focus on developing products intended to address specific health conditions. These targeted formulations are designed for conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and post-traumatic stress disorder. Thermic Sciences International has established a broad international distribution network, ensuring its products reach a wide consumer base. The company's market presence extends across the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan. Distribution channels include both online platforms, catering to a global digital audience, and traditional brick-and-mortar retail stores, providing physical access to its product offerings.
What Products and Services Does ENDO Offer?
- Develops and brings to market a wide range of hemp-based products.
- Offers health and wellness solutions formulated with hemp.
- Produces various cosmeceuticals, including skincare and personal care items.
- Creates nutraceuticals and food items infused with hemp.
- Manufactures over-the-counter personal care goods like oils, body washes, lotions, and balms.
- Develops specialized products targeting conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and PTSD.
- Distributes products internationally through online platforms and brick-and-mortar retail stores.
- Operates in the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan.
How Does ENDO Make Money?
- Generates revenue through the sale of its diverse portfolio of hemp-based health, wellness, cosmeceutical, nutraceutical, and food products.
- Utilizes a multi-channel distribution strategy, selling products both directly to consumers via online platforms and through traditional brick-and-mortar retail stores.
- Focuses on international market penetration, leveraging its distribution network across North America, South America, Europe, and Asia.
- Aims to differentiate through product innovation, particularly in developing hemp-based formulations for general wellness and specific therapeutic conditions.
What Industry Does ENDO Operate In?
Thermic Sciences International operates within the Basic Materials sector, specifically positioned in the Chemicals - Specialty industry with a focus on hemp-based products. This segment is part of a broader, evolving market driven by increasing consumer interest in natural health solutions and plant-derived ingredients. The company's diverse offerings, spanning health and wellness, cosmeceuticals, nutraceuticals, and food items, place it within a competitive landscape that includes both specialized hemp product manufacturers and larger consumer goods companies exploring plant-based alternatives. While the overall market for hemp-derived products is experiencing growth, Thermic Sciences International's niche involves both general consumer goods and more specialized formulations for specific health conditions. Its international distribution network provides a competitive avenue for market penetration, though it must contend with varying regulatory environments and established players in each geographic region.
Who Are ENDO's Key Customers?
- Consumers seeking natural health and wellness solutions derived from hemp.
- Individuals interested in hemp-infused personal care products for hair and skin.
- Customers looking for nutraceuticals and food items with hemp-based ingredients.
- Patients or individuals seeking complementary products for conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and PTSD.
- International markets across North America, South America, Europe, and Asia.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Thermic Sciences International operates in the Technology sector. It is headquartered in Colorado Springs, US. The company is led by CEO Raymond C. Dabney. ENDO has traded publicly since 1995.
Key Financial Metrics
Return on equity for Thermic Sciences International stands at 242.2%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Thermic Sciences International's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Insider Activity
12 transactions · 6 purchases, 0 sales, 6 other transactions · 3 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
ENDO Financials
ENDO Latest News
ENDO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ENDO.
Price Targets
Wall Street price target analysis for ENDO.
ENDO MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ENDO; grades run from A+ (80-100) to F (below 30).
ENDO OTC Market Information
The 'OTC Other' tier represents the lowest and most speculative segment of the over-the-counter market, distinct from major exchanges like the NYSE or NASDAQ. Companies on this tier typically do not meet the minimum financial standards or disclosure requirements for higher OTC tiers (OTCQX, OTCQB) or national exchanges. This classification often indicates a lack of regular financial reporting, limited transparency, and a higher degree of risk for investors. In contrast, NYSE and NASDAQ listed companies adhere to stringent listing standards, requiring regular filings with the SEC and robust corporate governance.
- OTC Tier: OTC Other
- Lack of transparent and consistent financial reporting, making it difficult for investors to assess the company's true financial health.
- Extremely low liquidity, which can lead to significant price volatility and difficulty in buying or selling shares.
- Increased susceptibility to market manipulation due to low trading volumes and limited oversight.
- Difficulty in obtaining reliable and timely information about the company's operations and strategic developments.
- Higher risk of delisting or cessation of trading due to non-compliance with even minimal OTC requirements.
- Verify any available financial filings and disclosures, however limited, directly from the company or OTC Markets.
- Scrutinize all news releases and corporate announcements for operational updates or strategic shifts.
- Investigate the background and track record of current management, including any past legal or regulatory issues.
- Assess the viability and competitive landscape of the company's core business operations in the hemp products market.
- Review any legal actions or regulatory sanctions against the company or its executives.
- Understand the company's share structure and potential for dilution.
- Evaluate any potential restructuring plans or efforts to improve its financial standing.
- Established in 1969, indicating a long operational history, albeit under a previous name.
- Possesses an international distribution network spanning multiple countries.
- Offers a diverse range of hemp-based products, suggesting an active business operation.
- A named CEO, Raymond C. Dabney, is publicly associated with the company.
ENDO Technology Stock FAQ
What are the key financial metrics investors watch for ENDO?
For Thermic Sciences International (ENDO), investors primarily focus on metrics reflecting its severe financial distress and operational viability. The market capitalization of $0.00B ($6,789) and a stock price of $0.00 are critical indicators of its current valuation and perceived risk. Its listing on the OTC Other tier is crucial, as it signifies limited public disclosure and heightened speculative risk.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data beyond market capitalization, stock price, and beta was provided.